{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:32:17Z","timestamp":1774578737962,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s15010-025-02719-1","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T17:33:34Z","timestamp":1766770414000},"page":"853-861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy, immunogenicity, and safety of typhoid conjugate vaccines in children and adolescents: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9307-0232","authenticated-orcid":false,"given":"Aashish","family":"Lamichhane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6909-0721","authenticated-orcid":false,"given":"Sadish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0887-2871","authenticated-orcid":false,"given":"Prakriti","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7730-2042","authenticated-orcid":false,"given":"Shishir","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0998-8258","authenticated-orcid":false,"given":"Sneha","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"2719_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101946","author":"C Masuet-Aumatell","year":"2021","unstructured":"Masuet-Aumatell C, Atouguia J. Typhoid fever infection\u2014antibiotic resistance and vaccination strategies: a narrative review. Travel Med Infect Dis. 2021. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101946.","journal-title":"Travel Med Infect Dis"},{"key":"2719_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(21)01340-4","volume":"398","author":"JA Crump","year":"2021","unstructured":"Crump JA, Oo WT. Salmonella typhi Vi polysaccharide conjugate vaccine protects infants and children against typhoid fever. Lancet. 2021;398:643\u20134.","journal-title":"Lancet"},{"key":"2719_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.4161\/hv.7.8.16282","volume":"7","author":"R Verma","year":"2011","unstructured":"Verma R, Bairwa M, Chawla S, Prinja S, Rajput M. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries. Hum Vaccin. 2011;7:883\u20135.","journal-title":"Hum Vaccin"},{"key":"2719_CR4","doi-asserted-by":"publisher","first-page":"taae140","DOI":"10.1093\/jtm\/taae140","volume":"31","author":"H Wang","year":"2024","unstructured":"Wang H, Zhang P, Zhao Q, Ma W. Global burden, trends and inequalities for typhoid and paratyphoid fever among children younger than 15\u00a0years over the past 30\u00a0years. J Travel Med. 2024;31:taae140.","journal-title":"J Travel Med"},{"key":"2719_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63070","author":"K Hamdulay","year":"2024","unstructured":"Hamdulay K, Rawekar R, Tayade A, Kumar S, Acharya S. Evolving epidemiology and antibiotic resistance in enteric fever: a comprehensive review. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.63070.","journal-title":"Cureus"},{"key":"2719_CR6","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1016\/S1473-3099(23)00500-5","volume":"24","author":"E Webster","year":"2024","unstructured":"Webster E, Palanco Lopez P, Kirchhelle C. Shifting targets: typhoid\u2019s transformation from an environmental to a vaccine-preventable disease, 1940\u20132019. Lancet Infect Dis. 2024;24:e232\u201344.","journal-title":"Lancet Infect Dis"},{"key":"2719_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6432580","author":"J Akram","year":"2020","unstructured":"Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively drug\u2010resistant (XDR) typhoid: evolution, prevention, and its management. Biomed Res Int. 2020. https:\/\/doi.org\/10.1155\/2020\/6432580.","journal-title":"Biomed Res Int"},{"key":"2719_CR8","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1016\/j.vaccine.2017.10.081","volume":"35","author":"Y Ni","year":"2017","unstructured":"Ni Y, Springer MJ, Guo J, Finger-Baker I, Wilson JP, Cobb RR, et al. Development of a synthetic Vi polysaccharide vaccine for typhoid fever. Vaccine. 2017;35:7121\u20136.","journal-title":"Vaccine"},{"key":"2719_CR9","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","volume":"71","author":"KA Syed","year":"2020","unstructured":"Syed KA, Saluja T, Cho H, et al. Review on the recent advances on typhoid vaccine development and challenges ahead. Clin Infect Dis. 2020;71:S141\u201350.","journal-title":"Clin Infect Dis"},{"key":"2719_CR10","doi-asserted-by":"publisher","first-page":"S172","DOI":"10.1093\/cid\/ciaa597","volume":"71","author":"K Date","year":"2020","unstructured":"Date K, Shimpi R, Luby S, et al. Decision making and implementation of the first public sector introduction of typhoid conjugate vaccine\u2014Navi Mumbai, India, 2018. Clin Infect Dis. 2020;71:S172\u20138.","journal-title":"Clin Infect Dis"},{"key":"2719_CR11","unstructured":"WHO. Comparison table of WHO prequalified typhoid conjugate vaccines (TCVs). WHO. 2021. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/10dee365-0868-4804-aa95-4d5435ab1425\/content. Accessed 30 Sept 2025"},{"key":"2719_CR12","unstructured":"Typhoid vaccine support. https:\/\/www.gavi.org\/types-support\/vaccine-support\/typhoid. Accessed 30 Sept 2025."},{"key":"2719_CR13","unstructured":"Family Welfare Division; Ministry of Health and Population (MoHP). Post Campaign Coverage Survey for TCV Campaign-2022 in Nepal. https:\/\/fwd.gov.np\/site_uploads\/articles\/tcv-post-c-10632862.pdf. Accessed 30 Sept 2025."},{"key":"2719_CR14","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18:e1230.","journal-title":"Campbell Syst Rev"},{"key":"2719_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"2719_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","volume":"344","author":"F Lin","year":"2001","unstructured":"Lin F, Ho V, Khiem H, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med. 2001;344:1263\u20139.","journal-title":"N Engl J Med"},{"key":"2719_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","volume":"12","author":"M Mitra","year":"2016","unstructured":"Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, et al. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study. Hum Vaccin Immunother. 2016;12:939\u201345.","journal-title":"Hum Vaccin Immunother"},{"key":"2719_CR18","doi-asserted-by":"publisher","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","volume":"9","author":"M Shakya","year":"2021","unstructured":"Shakya M, Voysey M, Theiss-Nyland K, et al. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial. Lancet Glob Health. 2021;9:e1561\u20138.","journal-title":"Lancet Glob Health"},{"key":"2719_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","volume":"398","author":"F Qadri","year":"2021","unstructured":"Qadri F, Khanam F, Liu X, et al. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial. Lancet. 2021;398:675\u201384.","journal-title":"Lancet"},{"key":"2719_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","volume":"403","author":"P Patel","year":"2024","unstructured":"Patel P, Liang Y, Meiring J, et al. Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children. Lancet. 2024;403:459\u201368.","journal-title":"Lancet"},{"key":"2719_CR21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(24)01494-6","volume":"404","author":"F Qadri","year":"2024","unstructured":"Qadri F, Khanam F, Zhang Y, et al. 5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial. Lancet (London, England). 2024;404:1419\u201329.","journal-title":"Lancet (London, England)"},{"key":"2719_CR22","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","volume":"381","author":"M Shakya","year":"2019","unstructured":"Shakya M, Colin-Jones R, Theiss-Nyland K, et al. Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal. N Engl J Med. 2019;381:2209\u201318.","journal-title":"N Engl J Med"},{"key":"2719_CR23","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","volume":"385","author":"P Patel","year":"2021","unstructured":"Patel P, Patel P, Liang Y, et al. Safety and efficacy of a typhoid conjugate vaccine in Malawian children. N Engl J Med. 2021;385:1104\u201315.","journal-title":"N Engl J Med"},{"key":"2719_CR24","first-page":"848","volume":"111","author":"K Date","year":"2024","unstructured":"Date K, LeBoa C, Hoffman SA, et al. Field effectiveness of a typhoid conjugate vaccine: the 2018 Navi Mumbai Pediatric TCV Campaign. Am J Trop Med Hyg. 2024;111:848\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"2719_CR25","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1016\/j.vaccine.2021.08.051","volume":"39","author":"R Batool","year":"2021","unstructured":"Batool R, Tahir Yousafzai M, Qureshi S, Ali M, Sadaf T, Mehmood J, et al. Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: a case-control study. Vaccine. 2021;39:5858\u201365.","journal-title":"Vaccine"},{"key":"2719_CR26","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","volume":"9","author":"MT Yousafzai","year":"2021","unstructured":"Yousafzai MT, Karim S, Qureshi S, et al. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study. Lancet Glob Health. 2021;9:e1154\u201362.","journal-title":"Lancet Glob Health"},{"key":"2719_CR27","doi-asserted-by":"publisher","first-page":"e589","DOI":"10.1016\/S2214-109X(23)00606-X","volume":"12","author":"R Batool","year":"2024","unstructured":"Batool R, Qamar ZH, Salam RA, Yousafzai MT, Ashorn P, Qamar FN. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis. Lancet Glob Health. 2024;12:e589\u201398.","journal-title":"Lancet Glob Health"},{"key":"2719_CR28","doi-asserted-by":"publisher","first-page":"107187","DOI":"10.1016\/j.ijid.2024.107187","volume":"147","author":"FN Qamar","year":"2024","unstructured":"Qamar FN, Qureshi S, Haq Z, et al. Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan. Int J Infect Dis. 2024;147:107187.","journal-title":"Int J Infect Dis"},{"key":"2719_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103100","author":"N Nampota-Nkomba","year":"2025","unstructured":"Nampota-Nkomba N, Nyirenda OM, Datta S, et al. Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children. eClinicalMedicine. 2025. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103100.","journal-title":"eClinicalMedicine"},{"key":"2719_CR30","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","volume":"39","author":"KM Vadrevu","year":"2021","unstructured":"Vadrevu KM, Raju D, Rani S, Reddy S, Sarangi V, Ella R, et al. Persisting antibody responses to Vi polysaccharide\u2013tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7 years following primary vaccination of children < 2 years of age with, or without, a booster vaccination. Vaccine. 2021;39:6682\u201390.","journal-title":"Vaccine"},{"key":"2719_CR31","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1016\/j.vaccine.2020.03.028","volume":"38","author":"FN Qamar","year":"2020","unstructured":"Qamar FN, Yousafzai MT, Khaliq A, et al. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan. Vaccine. 2020;38:3518\u201323.","journal-title":"Vaccine"},{"key":"2719_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1473-3099(21)00455-2","volume":"22","author":"G Kumar Rai","year":"2022","unstructured":"Kumar Rai G, Saluja T, Chaudhary S, et al. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. Lancet Infect Dis. 2022;22:529\u201340.","journal-title":"Lancet Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02719-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02719-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:54:06Z","timestamp":1774551246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02719-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02719-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There was no human participation in this study and informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}